Skip to content

Bronchogen

Synthetic lung/bronchial bioregulator. Studied for respiratory function improvement and pulmonary tissue support. Sequence: Ala-Glu-Asp-Leu.

Intelligence Profile

Clinical Applications

Based on the available evidence, Bronchogen appears to be a synthetic tetrapeptide (Ala-Asp-Glu-Leu) that has been investigated primarily in preclinical studies for respiratory and cellular regenerative applications.

Primary Investigated Uses

Obstructive Lung Disease Treatment
The most substantive clinical research focus has been on obstructive lung pathology. Preclinical studies in rat models have examined Bronchogen's potential anti-inflammatory and regenerative effects in this context. Research published in 2017 and 2015 investigated the compound's ability to modulate the morphofunctional state of bronchial epithelium in rats with experimentally induced obstructive lung conditions.

Cellular Regeneration and Aging
Studies have explored Bronchogen's role in cellular differentiation during aging processes. Research from 2012 suggests the peptide may have tissue-specific effects on cell differentiation, though the clinical implications remain unclear from the available evidence.

Mechanistic Research

Laboratory studies have investigated Bronchogen's molecular mechanisms, including:

  • Effects on DNA thermostability (2011)
  • Cellular penetration properties and DNA interaction (2011)
  • Gene expression modulation in plant models (2017)

Clinical Trial Activity

One completed clinical trial (NCT00746759, "Airway Epithelium Gene Expression: AEGIS IDE") appears related to airway research, though specific details about Bronchogen's role in this study are not provided in the available evidence.

Evidence Limitations

Important Note: The clinical evidence for Bronchogen is limited primarily to preclinical animal studies and mechanistic research. No substantial human clinical trial data demonstrating safety or efficacy for specific medical conditions is apparent from the available literature. The research appears to be in early investigational phases, with most studies conducted in laboratory or animal models.

This information is for educational purposes only and should not be considered medical advice. Consult healthcare professionals for guidance on specific medical conditions.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.